Clinical Trials Directory

Trials / Completed

CompletedNCT01472692

Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure

Treatment of Uric Acid With the Xanthine Oxidase Inhibitor Febuxostat: Effects on Blood Pressure, Metabolic Markers, and Aortic Stiffness in Prehypertensive

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
47 (actual)
Sponsor
University of California, San Diego · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

High normal blood pressure, also called prehypertension, is a significant problem. High uric acid in the blood, the same thing that causes gout, may cause higher blood pressures. The investigators plan to monitor the effects of the drug febuxostat(trade name Uloric) on blood pressure and stiffness of the main blood vessels and see if lowering uric acid has any effect.

Conditions

Interventions

TypeNameDescription
DRUGFebuxostat80mg PO daily for 8 weeks

Timeline

Start date
2011-10-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2011-11-16
Last updated
2019-12-16
Results posted
2019-12-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01472692. Inclusion in this directory is not an endorsement.